Riboflavin (Vitamin B2) and Migraine — What Does the Meta-Analysis Show?

Migraine is a neurological disease that can knock someone out of daily functioning for hours at a time, and with chronic migraine, for many days a month. Recurring attacks, often accompanied by heightened sensitivity to light and sound, nausea, or visual aura, have a real impact on work, relationships, and quality of life, not just on how someone feels on a given day. This is exactly why, alongside acute treatment of a single attack, so much weight is placed on prevention — interventions meant to reduce the frequency and severity of attacks over the long term, rather than relieve them once they've already started.

This distinction is crucial and easy to confuse. Acute treatment (e.g., triptans, nonsteroidal anti-inflammatory drugs) works during an ongoing attack and aims to relieve pain as quickly as possible. Prevention works quite differently — it's taken regularly, for weeks or months, regardless of whether an attack is currently happening, and its goal is to reduce the number of future episodes. Riboflavin, like magnesium, which we cover in a separate article on magnesium and migraine, belongs to this second category — it won't help during an ongoing attack, but with regular use it may reduce how often and how severely migraine returns at all.

Riboflavin (vitamin B2) is a precursor of two key coenzymes — FAD (flavin adenine dinucleotide) and FMN (flavin mononucleotide) — essential in the mitochondrial respiratory chain, the process by which cells produce energy in the form of ATP. The hypothesis behind using riboflavin in migraine assumes that some migraine patients experience transient dysfunction of energy metabolism in the mitochondria of brain neurons — nerve cells at certain moments have a reduced ability to efficiently produce energy, which may lower the excitability threshold and favor triggering a migraine attack.

This is a completely different point of intervention than magnesium, which affects nerve transmission, blood vessel function, and inflammatory processes instead. Riboflavin, by supplying substrate for FAD and FMN production, is theorized to improve the energy capacity of neuronal mitochondria and thereby reduce the frequency of situations that trigger an attack. This is still a mechanistic hypothesis, supported indirectly by imaging studies suggesting disturbances in brain energy metabolism in some migraine patients, rather than a fully proven, unambiguous cause-and-effect chain.

The paper by Chen and colleagues, published in 2022 in the journal Nutritional Neuroscience, is a systematic review and meta-analysis evaluating the effect of riboflavin supplementation on migraine prevention.

The I² statistic tells you how much of the variability in results across component studies comes from genuine methodological differences (dose, duration, patient population, measurement method) rather than random chance. Values above 75% are generally considered high heterogeneity. In this meta-analysis, migraine days (I²=89%) and pain intensity (I²=84%) showed exactly that kind of high heterogeneity, while attack duration (I²=0%) was very consistent across studies on that measure.

In practice, this means the effect of riboflavin isn't uniform across all component studies — some may have shown a stronger effect, others a weaker one, depending on differences in study design. This doesn't undermine the direction of the conclusion (improvement compared with the control group), but it warns against treating the reported p-values as a precise, unambiguous measure of exactly how many attacks or migraine days a given person will lose.

In practice, this means someone dealing with recurring migraine, looking for a preventive option with a well-documented, mild safety profile, has in riboflavin another path independent of magnesium, backed by repeated clinical trial results — not a miracle cure, but a real option worth considering together with a doctor.

Riboflavin isn't as widely known in the migraine context as magnesium, but the evidence behind it is concrete and repeatable — nine clinical studies showing a consistent direction of effect across four different migraine parameters is more than a single, isolated observation. This is still moderate-strength evidence, limited by the size of the study base and heterogeneity in some results, but sufficient to treat riboflavin as a real, worthwhile preventive option, not a curiosity on the supplement shelf.

If you're dealing with recurring migraine and looking for a preventive option with a well-documented, mild safety profile, riboflavin — alongside magnesium — is one of the few supplemental interventions backed by a meta-analysis rather than a single, small study. The decision on dosing and possibly combining it with other prevention methods is worth discussing with a neurologist, especially if the migraine is chronic or the attacks are frequent and severe.